Nev. Admin. Code § 453A.655

Current through June 11, 2024
Section 453A.655 - Limited testing for research and development purposes
1. A cultivation facility or a facility for the production of edible marijuana products or marijuana-infused products may conduct operations and request limited laboratory testing for research and development purposes.
2. A cultivation facility or facility for the production of edible marijuana products or marijuana-infused products described in subsection 1 shall:
(a) Notify the Division of its intent to conduct research and development on a form prescribed by the Division by electronic mail at MMER&DTesting@health.nv.gov before sending a sample to an independent testing laboratory;
(b) Quarantine each batch, lot or production run in a separate quarantine area and label each batch, lot or production run with a distinctive label containing "R&D QUARANTINE" as a header and footer in 20-point white font and a red background;
(c) Account for all marijuana subject to quarantine pursuant to paragraph (b) in its inventory control system;
(d) Limit all research and development operations to clearly segregated and designated areas or rooms marked "R&D CULTIVATION AREA" or "R&D PRODUCTION AREA" on 8 1/2 by 11 inch signs with a red background and white lettering, posted at the entrance to the area or room and along the walls of the area or room, with a minimum of one sign for every 300 square feet of the area or room; and
(e) Perform research and development operations in a grow room only if the plants used for such operations are designated and separated from other plants.
3. A cultivation facility or facility for the production of edible marijuana products or marijuana-infused products operating as described in subsection 1 may request limited testing protocols from an independent testing laboratory for research and development purposes.
4. An independent testing laboratory that performs testing for a cultivation facility or facility for the production of edible marijuana products or marijuana-infused products described in subsection 1 shall report the results of the testing to the medical marijuana establishment and to the Division by electronic mail at MMER&DTesting@health.nv.gov. The independent testing laboratory shall clearly mark the test results with "R&D TESTING ONLY -- NOT FOR RESALE" on the header and footer of the report in 20-point white font and a red background.
5. A batch, lot or production run produced for research and development purposes pursuant to this section which fails quality assurance testing need not be destroyed.
6. A batch, lot or production run originally produced for research and development purposes pursuant to this section may not be sold to a medical marijuana dispensary until the batch, lot or production run has undergone and passed all testing required by NAC 453A.654.

Nev. Admin. Code § 453A.655

Added to NAC by Div. of Pub. & Behavioral Health by R148-15A, eff. 9/9/2016
NRS NRS 453A.370